Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-99.66	-191.95	57005.95
Graham Fair Price	63.73	0.29	0.17
PEG	-85.47	-0.36	2.51
Price/Book	-23.33	4.33	5.64
Price/Cash Flow	-54.60	-370.49	816.13
Prices/Earnings	72.36	-62.91	-227.59
Price/Sales	-13.96	41.21	47.89
Price/FCF	-54.60	-370.49	816.13
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-14.17	0.61	0.72
Operating Margin	-78.32	-0.13	-0.07
ROA	-174.77	-0.01	< 0.005
ROE	< 0.005	-0.02	-177.36
ROIC	< 0.005	-0.01	-121.19
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	< 0.005	137.70
Dividends QOQ	< 0.005	-0.08	13283.34
EBIT QOQ	0.87	-0.56	-35.09
EPS QOQ	0.91	-1.72	90.21
FCF QOQ	1.59	-2.66	67.42
Revenue QOQ	0.02	-0.12	651.12
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	2301.97	1934.11	-15.98
Days Sales Outstanding (DSO)	114.91	154.23	34.22
Inventory Turnover	0.04	0.05	19.02
Debt/Capitalization	0.09	0.09	0.81
Quick Ratio	0.77	0.81	5.17
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.47	0.49	4.68
Cash	0.02	0.01	-32.89
Capex	< 0.005	0.00	inf
Free Cash Flow	< 0.005	< 0.005	66.05
Revenue	0.06	0.05	-12.39
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	4.40	4.27	-2.89
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	658.51	-3.39	-99.48
Naive Interpretation	Member

06 - Financial Health · Bad

Rating